NCT01075464View on ClinicalTrials.gov

A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Solid Cancers
Interventions
DRUG

MEGF0444A

Intravenous escalating dose

DRUG

bevacizumab

Intravenous repeating dose

DRUG

paclitaxel

Intravenous repeating dose

Trial Locations (5)

33612

Tampa

37203

Nashville

85258

Scottsdale

90404

Santa Monica

94115

San Francisco

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY